Skip to main content

Table 1 Baseline characteristics and change in physical function and in the anchors after 12–18 months

From: Minimal clinically important decline in physical function over one year: EPOSA study

 

Baseline

Change: 12–18 months follow-up - baseline

P

Age, n, mean (SD), median (IQR), y

1886

73.8 ± 5.0

73 (70.77)

    

Female Sex, n (%)

1886

977 (51.8)

    

High education, n (%)

1886

1120 (58.8)

    

Country, n (%)

1886

      

 Italy

 

312 (16.8)

    

 The Netherlands

 

407 (22.0)

    

 Spain

 

413 (22.4)

    

 Sweden

 

392 (23.0)

    

 UK

 

362 (15.8)

    

Clinical hand OA, n (%)

1886

1842 (16.7)

    

Clinical hip/knee OA, n (%)

1886

1845 (22.6)

    

AUSCAN for hand OAa, n, mean ± SD, median (IQR)

 Physical function

1842

9.1 ± 15.4

0 (0,11)

1842

1.1 ± 11.3

0 (0,4)

<.0001

 Painc

1842

7.6 ± 15.2

0 (0,5)

1842

1.7 ± 14.4

0 (0,0)

0.1949

 Stiffness

1842

10.0 ± 18.7

0 (0,25)

1842

1.0 ± 17.2

0 (0,0)

0.1358

WOMAC for hip/knee OAa, n, mean ± SD, median (IQR)

 Physical function

1845

8.5 ± 13.2

2 (0,12)

1845

1.5 ± 11.3

0 (−1,4)

0.0123

 Pain

1845

10.0 ± 14.3

5 (0,15)

1845

1.4 ± 13.2

0 (−5,5)

0.2579

 Stiffness

1845

12.9 ± 18.6

0 (0,25)

1845

0.3 ± 17.9

0 (0,12)

0.0390

Grip strengthb, n, mean ± SD, median (IQR), kg

1862

27.7 ± 10.2

26 (20,35)

1826

−1.1 ± 5.8

−1 (−3.5,1.5)

0.0004

Walking-test timec, n, mean ± SD, median (IQR), sec

1854

3.3 ± 1.6

3 (2.3,3.8)

1830

0.1 ± 1.6

0 (−0.5,0.6)

<.0001

HADS anxietyd, n, mean ± SD, median (IQR)

1886

4.5 ± 3.5

4 (2,7)

1872

−0.6 ± 2.6

−1 (−2,1)

<.0001

HADS depressiond, n, mean ± SD, median (IQR)

1886

3.5 ± 3.0

3 (1,5)

1875

−0.3 ± 2.4

0 (−1,1)

<.0001

EQ-5D-5 Le, n, mean ± SD, median (IQR)

1876

0.8 ± 0.2

0.8 (0.7,1.0)

1855

0.0 ± 0.2

0 (0.0,0.1)

0.0059

EQ VASf, n, mean ± SD, median (IQR)

1882

76.5 ± 16.2

80 (70,90)

1875

−0.5 ± 15.6

0 (−10,5)

0.0114

  1. Weighted data. Numbers of subjects, age, and sex were unweighted data. Except where indicated otherwise, values are the percent of subjects
  2. EPOSA European Project on OSteoArthritis, SD Standard deviation, IQR interquartile range, AUSCAN AUStralian/CANadian Osteoarthritis Hand Index, WOMAC Western Ontario and McMaster Universities Osteoarthritis Index, OA osteoarthritis, HADS Hospital Anxiety and Depression Scales, EQ-5D-5 L Health status using five dimensions, EQ VAS Health status using the visual analogue scale
  3. a Possible scores range from 0 to 100, with 100 indicating worse health status. b Lower values indicate worse performance. c Higher values indicate worse performance. d Possible scores range from 0 to 21, a score ≥ 8 indicates anxiety and/or depression. e Possible scores range from − 0.594 to 1, lower values indicating worse health status. f Possible scores range from 0 to 100, with 0 indicating worse health status
  4. The P are bold where they are less than or equal to the significance level cut-off of 0.05